How does CLB's Q1 2025 EPS forecast compare historically?

Core Laboratories' (CLB) Q1 2025 EPS forecast is below the historical average when compared to the past few quarters.

1. **Q1 2025 Forecast**: The company provided EPS guidance of $0.120-$0.160 for Q1 2025, compared to the consensus estimate of $0.210.
2. **Historical Perspective**:
- In Q3 2024, CLB's EPS was $0.25, which was higher than the Q1 2025 forecast range.
- The EPS in Q2 2024 was $0.22, also above the Q1 2025 forecast.
- Q1 2024's EPS was $0.19, below the Q1 2025 forecast range, but considering the historical trend, it was still relatively high compared to the Q1 2025 guidance.
- The EPS in Q3 2023 was $0.25, indicating a seasonal fluctuation where Q3 EPS is typically higher than Q1.

|code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|CLB|CLB.N|Core Laboratories|2024 Q2|-60.416666666666664|0.19|169|
|CLB|CLB.N|Core Laboratories|2024 Q3|31.57894736842105|0.25|169|
|CLB|CLB.N|Core Laboratories|2024 Q4|199.99999999999997|0.15|169|

|code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|CLB|CLB.N|Core Laboratories|2023 Q4||0.05|169|
|CLB|CLB.N|Core Laboratories|2024 Q1|40.00000000000001|0.07|169|
|CLB|CLB.N|Core Laboratories|2024 Q2|-60.416666666666664|0.19|169|
|CLB|CLB.N|Core Laboratories|2024 Q3|31.57894736842105|0.25|169|

|code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|CLB|CLB.N|Core Laboratories|2023 Q3|18.75|0.19|169|
|CLB|CLB.N|Core Laboratories|2023 Q4||0.05|169|
|CLB|CLB.N|Core Laboratories|2024 Q1|40.00000000000001|0.07|169|
|CLB|CLB.N|Core Laboratories|2024 Q2|-60.416666666666664|0.19|169|

|code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|CLB|CLB.N|Core Laboratories|2023 Q2|219.99999999999997|0.48|169|
|CLB|CLB.N|Core Laboratories|2023 Q3|18.75|0.19|169|
|CLB|CLB.N|Core Laboratories|2023 Q4||0.05|169|
|CLB|CLB.N|Core Laboratories|2024 Q1|40.00000000000001|0.07|169|

|code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|CLB|CLB.N|Core Laboratories|2023 Q1|225|0.05|169|
|CLB|CLB.N|Core Laboratories|2023 Q2|219.99999999999997|0.48|169|
|CLB|CLB.N|Core Laboratories|2023 Q3|18.75|0.19|169|

The historical comparison suggests that Q1 2025's EPS forecast is below the recent past performance of the company, indicating a potential decline or a cautious outlook from the company for the upcoming quarter.